ArticleCirculation. Cardiovascular interventions2017
Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis.
Abstract read
In one paragraph
Article in Circulation. Cardiovascular interventions, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Risk Prediction Models for Hospital Readmission After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.Reviews in cardiovascular medicine · 2025Pooled it
- Factors affecting hospital readmission rates following an acute coronary syndrome: A systematic review.Journal of clinical nursing · 2022Pooled it
- Evaluation of a Meds-to-Beds Program to Reduce Readmissions After Percutaneous Coronary Intervention.JACC. Advances · 2026Article
- Clinical and Economic Burden Following Percutaneous Coronary Intervention for STEMI: A US Real-World Evidence Study.ClinicoEconomics and outcomes research : CEOR · 2026Article
- Evaluating the potential of the outcome-oriented nursing assessment for acute care (ePA-AC) to identify cardiovascular patients at risk for unplanned 30- and 180-day all-cause readmission: Development and validation of a routine data-based model.American heart journal plus : cardiology research and practice · 2025Article
- Benefits of wearable-based cardiac rehabilitation interventions in secondary prevention of coronary artery disease - a systematic review and meta-analysis.American journal of preventive cardiology · 2025Article
- Trends in Readmissions Rates and Mortality after Cardiac Resynchronization Therapy in Patients with Nonischemic Cardiomyopathy.Current cardiology reviews · 2025Article
- Activity counseling early postelective percutaneous coronary intervention (ACE-PCI): Mixed-methods pilot randomized controlled trial.Health science reports · 2024Article
- Discharge Readiness and Associated Factors Among Patients with Coronary Heart Disease After Stent Implantation: A Cross-Sectional Single Center Study.Patient preference and adherence · 2024Article
- Upgrading Care: Digital Cardiology Interventions to Reduce Risk.JACC. Advances · 2023Article
- Simultaneous bilateral total knee arthroplasty has higher in-hospital complications than both staged surgeries: a nationwide propensity score matched analysis of 38,764 cases.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023Article
- Early vs. Late Readmission following Percutaneous Coronary Intervention: Predictors and Impact on Long-Term Outcomes.Journal of clinical medicine · 2023Article
- In-hospital outcomes and readmission in older adults treated with percutaneous coronary intervention for stable ischemic heart disease.Journal of geriatric cardiology : JGC · 2022Article
- Article
- Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database).Clinical cardiology · 2021Article
- Incidence and Predictors of Unplanned Hospital Readmission after Percutaneous Coronary Intervention.Journal of clinical medicine · 2020Article
- Associations Between Hospital Length of Stay, 30-Day Readmission, and Costs in ST-Segment-Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis.Journal of the American Heart Association · 2020Observational
- Association of Hospital Discharge Against Medical Advice With Readmission and In-Hospital Mortality.JAMA network open · 2020Article
- Trends and outcomes of non-primary PCI at sites without cardiac surgery on-site: The early Michigan experience.PloS one · 2020Article
- Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus.The Journal of international medical research · 2019Article
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Avnish TripathiFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
J Dawn AbbottFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Gregg C FonarowFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Abdur R KhanFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Neil G BarryFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Sohail IkramFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Rita CoramFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Verghese MathewFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Ajay J KirtaneFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Brahmajee K NallamothuFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Glenn A HirschFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Deepak L BhattFrom the Division of Cardiology, University of Louisville Medical School, KY (A.T., A.R.K., N.G.B., S.I., R.C., G.A.H.); Division of Cardiology, Warren Alpert Medical School, Brown University, Providence, RI (J.D.A.); Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA (G.C.F.); Division of Cardiology, Stritch School of Medicine, Loyola University, Chicago, IL (V.M.); Division of Cardiology, Columbia University Medical Center/NewYork-Presbyterian Hospital (A.J.K.); Department of Internal Medicine, University of Michigan, Ann Arbor (B.K.N.); and Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.). dlbhattmd@post.harvard.edu.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe association of short-term readmissions after percutaneous coronary intervention (PCI) on healthcare costs has not been well studied. METHODS AND
resultsThe Healthcare Cost and Utilization Project National Readmission Database encompassing 722 US hospitals was used to identify index PCI cases in patients ≥18 years old. Hierarchical regression analyses were used to examine the factors associated with risk of 30-day readmission and higher cumulative costs. We evaluated 206 869 hospitalized patients who survived to discharge after PCI from January through November 2013 and analyzed readmissions over 30 days after discharge. A total of 24 889 patients (12%) were readmitted within 30 days, with rates ranging from 6% to 17% across hospitals. Among the readmitted patients, 13% had PCI, 2% had coronary artery bypass surgery, and 3% died during the readmission. The most common reasons for readmission included nonspecific chest pain/angina (24%) and heart failure (11%). Mean cumulative costs were higher for those with readmissions ($39 634 versus $22 058;
conclusionsIn a national sample of inpatient PCI cases, 30-day readmissions were associated with a significant increase in cumulative costs. The majority of readmissions were because of low-risk chest pain that did not require any intervention. Ongoing effort is warranted to recognize and mitigate potentially preventable post-PCI readmissions.
Indexed as
Hospital CostsAdolescentAdultAgedAngina PectorisChi-Square DistributionCoronary DiseaseDatabases, FactualFemaleHospital MortalityHumansLinear ModelsLogistic ModelsMaleMedicareMiddle Agedchest paincoronary artery bypassheart failureinpatientspercutaneous coronary intervention
Identifiers
PMID
29246918What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.